HUMAN SERVICES recommended it, on May 8, 2017.
2017–2018 Regular Session
House Resolution 17
A Resolution requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Jan 23 – May 8
- Jan 23Introduced
- Jan 25Sent to HUMAN SERVICES
- May 8HUMAN SERVICES recommended it
All 15 actions, as published
- Jan 23INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35, Jan. 23, 2017 [House]House of Representatives
- Jan 25Referred to HUMAN SERVICES, Jan. 25, 2017 [House]House of Representatives
- May 8Reported as committed, May 8, 2017 [House]House of Representatives
- Jun 21Laid on the table, June 21, 2017 [House]House of Representatives
- Jun 21Removed from table, June 21, 2017 [House]House of Representatives
- Sep 12Laid on the table, Sept. 12, 2017 [House]House of Representatives
- Sep 12Removed from table, Sept. 12, 2017 [House]House of Representatives
- Oct 26Laid on the table, Oct. 26, 2017 [House]House of Representatives
- Oct 26Removed from table, Oct. 26, 2017 [House]House of Representatives
- Feb 5, 2018Laid on the table, Feb. 5, 2018 [House]House of Representatives
- Feb 5, 2018Removed from table, Feb. 5, 2018 [House]House of Representatives
- May 23, 2018Laid on the table, May 23, 2018 [House]House of Representatives
- May 23, 2018Removed from table, May 23, 2018 [House]House of Representatives
- Sep 13, 2018Laid on the table, Sept. 13, 2018 [House]House of Representatives
- Sep 13, 2018Removed from table, Sept. 13, 2018 [House]House of Representatives